Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally.

Belshe RB, Gruber WC.

Pediatr Infect Dis J. 2000 May;19(5 Suppl):S66-71. No abstract available.

PMID:
10821474
2.

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.

Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD; D153-P504 LAIV Study Group.

Pediatr Infect Dis J. 2009 May;28(5):365-71. doi: 10.1097/INF.0b013e31819219b8.

PMID:
19395948
3.

The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children.

Block SL, Heikkinen T, Toback SL, Zheng W, Ambrose CS.

Pediatr Infect Dis J. 2011 Mar;30(3):203-7. doi: 10.1097/INF.0b013e3181faac7c.

PMID:
20935591
4.

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children.

Marchisio P, Cavagna R, Maspes B, Gironi S, Esposito S, Lambertini L, Massimini A, Herzog C, Principi N.

Clin Infect Dis. 2002 Jul 15;35(2):168-74. Epub 2002 Jun 19.

5.

Influenza virus vaccines in children and their impact on the incidence of otitis media.

Rafei K.

Semin Pediatr Infect Dis. 2002 Apr;13(2):129-33. Review.

PMID:
12122951
6.

Cold-adapted, live attenuated intranasal influenza virus vaccine.

Zangwill KM.

Pediatr Infect Dis J. 2003 Mar;22(3):273-4. Review. No abstract available.

PMID:
12634591
7.
8.

Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.

Vesikari T, Karvonen A, Smith HM, Dunning A, Razmpour A, Saville MK, Gruber WC, Forrest BD.

Pediatrics. 2008 Mar;121(3):e568-73. doi: 10.1542/peds.2007-1405. Epub 2008 Feb 25.

PMID:
18299305
9.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
10.

Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children.

Heikkinen T, Block SL, Toback SL, Wu X, Ambrose CS.

Pediatr Infect Dis J. 2013 Jun;32(6):669-74. doi: 10.1097/INF.0b013e3182840fe7.

PMID:
23271441
11.

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.

Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD; CAIV-T Pediatric Day Care Clinical Trial Network.

Pediatrics. 2006 Dec;118(6):2298-312.

PMID:
17142512
12.

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.

Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, Walker R, Hessel C, Cordova J, Mendelman PM.

Pediatr Infect Dis J. 2004 Feb;23(2):138-44.

PMID:
14872180
13.

Demystifying FluMist, a new intranasal, live influenza vaccine.

Mossad SB.

Cleve Clin J Med. 2003 Sep;70(9):801-6. Review.

PMID:
14518575
14.

Cold-adapted influenza vaccines.

Bradshaw J, Wright PF.

Curr Opin Pediatr. 2002 Feb;14(1):95-8. Review.

PMID:
11880742
15.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
16.

Update on influenza A (H1N1) 2009 monovalent vaccines.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1.

17.

Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.

Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD.

Pediatr Infect Dis J. 2004 Nov;23(11):1053-5.

PMID:
15545863
18.

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.

Halasa N, Englund JA, Nachman S, Weinberg GA, Huber VC, Allison K, Dubovsky F, Yi T, McCullers JA, Flynn PM.

Vaccine. 2011 May 31;29(24):4110-5. doi: 10.1016/j.vaccine.2011.03.097. Epub 2011 Apr 13.

PMID:
21496468
19.

Impact of pneumococcal and influenza vaccines on otitis media.

Jenson HB, Baltimore RS.

Curr Opin Pediatr. 2004 Feb;16(1):58-60. Review.

PMID:
14758115
20.

[Vaccinal prevention of influenza in children].

Zykov MP, Vasil'eva RI.

Tr Inst Im Pastera. 1982;58:30-8. Russian. No abstract available.

PMID:
6764981

Supplemental Content

Support Center